National Health Investors, Inc. (NHI)

National Health Investors Stock Forecast

Stock Price Forecast

The 4 analysts that cover National Health Investors stock have a consensus rating of "Buy" and an average price target of $85.75, which forecasts a 21.05% increase in the stock price over the next year. The lowest target is $77 and the highest is $92.

Price Target: $85.75 (+21.05%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$77	$85.75	$88	$92
Change	+8.70%	+21.05%	+24.22%	+29.87%

Analyst Ratings

The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	1	1	1	1
Buy	4	4	2	2	2	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	5	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $76 → $77	Hold	Maintains	$76 → $77	+8.70%	Jun 9, 2025
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $70 → $76	Hold	Maintains	$70 → $76	+7.28%	Mar 19, 2025
Richard Anderson Wedbush	Wedbush	Buy Reiterates $88	Buy	Reiterates	$88	+24.22%	Mar 17, 2025
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $78 → $72	Hold	Maintains	$78 → $72	+1.64%	Dec 23, 2024
John Kilichowski Wells Fargo	Wells Fargo	Buy → Hold Initiates $81 → $86	Buy → Hold	Initiates	$81 → $86	+21.40%	Oct 1, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

358.96M

Increased by 6.97%

from 335.58M

Revenue Next Year

397.38M

Increased by 10.70%

from 358.96M

EPS This Year

3.11

Decreased by -0.48%

from 3.13

EPS Next Year

3.32

Increased by 6.74%

from 3.11

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	329.69M	297.17M	278.76M	320.39M	335.58M	358.96M	397.38M	432.25M
Revenue Growth	3.65%	-9.86%	-6.19%	14.93%	4.74%	6.97%	10.70%	8.77%
EPS	4.14	2.44	1.48	3.13	3.13	3.11	3.32	3.39
EPS Growth	12.81%	-41.06%	-39.34%	111.16%	0.16%	-0.48%	6.74%	1.86%
Forward PE	-	-	-	-	-	22.74	21.31	20.92
No. Analysts	-	-	-	-	-	6	6	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	416.8M	512.5M	601.7M
Avg	359.0M	397.4M	432.3M
Low	328.3M	343.8M	345.4M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	24.2%	42.8%	51.4%
Avg	7.0%	10.7%	8.8%
Low	-2.2%	-4.2%	-13.1%

EPS Forecast

EPS	2025	2026	2027
High	3.35	3.61	3.63
Avg	3.11	3.32	3.39
Low	2.95	3.12	3.20

EPS Growth

EPS Growth	2025	2026	2027
High	7.0%	16.0%	9.3%
Avg	-0.5%	6.7%	1.9%
Low	-5.8%	0.1%	-3.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.